Market Overview:
The global injection port septa market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for advanced green septa, rising prevalence of chronic diseases, and growing number of biotechnology and pharmaceutical companies. Based on type, the global injection port septa market is segmented into advanced green septa, BTO septa, and others. The advanced green septum segment is expected to grow at a higher CAGR during the forecast period owing to its benefits such as easy handling and reduced environmental impact. Based on application, the global injection port septa market is segmented into biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, research and academic institutes, contract research organizations (CROs), medical device manufacturers (MDMs), drug discovery centers & contract manufacturing organizations (CMOs). The hospitals & diagnostic laboratories segment accounted for the largest share of the global injection port septum market in 2017 owing to rising demand for diagnostics services across regions.
Product Definition:
An injection port septa is a thin, disk-like rubber membrane that is inserted into the opening of an injection port to prevent the contents of the syringe from leaking out. The septa is pierced by the needle of the syringe when medication or other fluid is injected into the port.
Advanced Green Septa:
Advanced green septa are the latest trend in the market and have been used for about a year. They are made from an inert material, which is then coated with a thin layer of plastic to make it water-soluble. It has several advantages over conventional port septa; it does not block blood vessels, reduces pain by up to 50% and causes less damage to nearby tissues & organs when compared with injections.
BTO Septa:
BTO septa are also known as Blood Tissue Owing to their ability to restrict the movement of blood in vessels. They are used for treating conditions such as varicose veins, spider veins, and chronic leg ulcers among others. BTO septa is a minimally invasive procedure that involves injecting a small amount of sterile water into the vein through which blood travels.
Application Insights:
The biotechnology and pharmaceutical companies segment dominated the global market in terms of revenue share in 2017. This is attributed to the high usage rate of septa among biotechnology and pharmaceutical companies. The hospitals and diagnostic laboratories segment is expected to witness significant growth over the forecast period owing to an increase in hospital construction across various regions coupled with a rise in demand for advanced healthcare services.
Injection ports are used extensively for administration of drugs into patients¢â‚¬â„¢ bodies at different levels, from subcutaneous level till intravenous level.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities and rising adoption of new technologies across various sectors, such as healthcare and life sciences, manufacturing industries, food & beverage sector, among others. Moreover, presence of major players in this region is also contributing toward growth of the market for INA septa in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing number of biotechnology and pharmaceutical companies investing in India due to availability of skilled human resources coupled with low operational costs involved compared with developed countries like U.S., Canada etc.; hence driving regional demand for INA septa over the forecast period from 2018 To 2030 (See Table 1).
Growth Factors:
- Increasing demand for Injection Port Septa in the medical industry for drug delivery and other applications
- Growing number of research and development activities for novel septa products
- Rising popularity of injection port devices among patients and healthcare professionals
- Technological advancements in the manufacturing of septa products
- Growing awareness about safety and efficacy of injection port devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Injection Port Septa Market Research Report
By Type
Advanced Green Septa, BTO Septa, Others
By Application
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
By Companies
PerkinElmer, Agilent, Worldwide Glass Resources, Merck, Chromatography Research Supplies, Restek Corporation, Pawling Engineered Products, Shimadzu, GL Sciences Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Injection Port Septa Market Report Segments:
The global Injection Port Septa market is segmented on the basis of:
Types
Advanced Green Septa, BTO Septa, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PerkinElmer
- Agilent
- Worldwide Glass Resources
- Merck
- Chromatography Research Supplies
- Restek Corporation
- Pawling Engineered Products
- Shimadzu
- GL Sciences Inc.
Highlights of The Injection Port Septa Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Advanced Green Septa
- BTO Septa
- Others
- By Application:
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injection Port Septa Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An injection port septa is a small, thin partition that separates the air-filled space inside an engine from the fuel and oil that are injected into the engine.
Some of the key players operating in the injection port septa market are PerkinElmer, Agilent, Worldwide Glass Resources, Merck, Chromatography Research Supplies, Restek Corporation, Pawling Engineered Products, Shimadzu, GL Sciences Inc..
The injection port septa market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injection Port Septa Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injection Port Septa Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injection Port Septa Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injection Port Septa Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injection Port Septa Market Size & Forecast, 2018-2028
4.5.1 Injection Port Septa Market Size and Y-o-Y Growth
4.5.2 Injection Port Septa Market Absolute $ Opportunity
Chapter 5 Global Injection Port Septa Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Injection Port Septa Market Size Forecast by Type
5.2.1 Advanced Green Septa
5.2.2 BTO Septa
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Injection Port Septa Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Injection Port Septa Market Size Forecast by Applications
6.2.1 Biotechnology and Pharmaceutical Companies
6.2.2 Hospitals and Diagnostic Laboratories
6.2.3 Research and Academic Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Injection Port Septa Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Injection Port Septa Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Injection Port Septa Analysis and Forecast
9.1 Introduction
9.2 North America Injection Port Septa Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Injection Port Septa Market Size Forecast by Type
9.6.1 Advanced Green Septa
9.6.2 BTO Septa
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Injection Port Septa Market Size Forecast by Applications
9.10.1 Biotechnology and Pharmaceutical Companies
9.10.2 Hospitals and Diagnostic Laboratories
9.10.3 Research and Academic Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Injection Port Septa Analysis and Forecast
10.1 Introduction
10.2 Europe Injection Port Septa Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Injection Port Septa Market Size Forecast by Type
10.6.1 Advanced Green Septa
10.6.2 BTO Septa
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Injection Port Septa Market Size Forecast by Applications
10.10.1 Biotechnology and Pharmaceutical Companies
10.10.2 Hospitals and Diagnostic Laboratories
10.10.3 Research and Academic Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Injection Port Septa Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Injection Port Septa Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Injection Port Septa Market Size Forecast by Type
11.6.1 Advanced Green Septa
11.6.2 BTO Septa
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Injection Port Septa Market Size Forecast by Applications
11.10.1 Biotechnology and Pharmaceutical Companies
11.10.2 Hospitals and Diagnostic Laboratories
11.10.3 Research and Academic Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Injection Port Septa Analysis and Forecast
12.1 Introduction
12.2 Latin America Injection Port Septa Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Injection Port Septa Market Size Forecast by Type
12.6.1 Advanced Green Septa
12.6.2 BTO Septa
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Injection Port Septa Market Size Forecast by Applications
12.10.1 Biotechnology and Pharmaceutical Companies
12.10.2 Hospitals and Diagnostic Laboratories
12.10.3 Research and Academic Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Injection Port Septa Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Injection Port Septa Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Injection Port Septa Market Size Forecast by Type
13.6.1 Advanced Green Septa
13.6.2 BTO Septa
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Injection Port Septa Market Size Forecast by Applications
13.10.1 Biotechnology and Pharmaceutical Companies
13.10.2 Hospitals and Diagnostic Laboratories
13.10.3 Research and Academic Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Injection Port Septa Market: Competitive Dashboard
14.2 Global Injection Port Septa Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PerkinElmer
14.3.2 Agilent
14.3.3 Worldwide Glass Resources
14.3.4 Merck
14.3.5 Chromatography Research Supplies
14.3.6 Restek Corporation
14.3.7 Pawling Engineered Products
14.3.8 Shimadzu
14.3.9 GL Sciences Inc.
